CA
NZ
UK
AU
IND
US
Bronstein, Gewirtz and Grossman's outreach placesShareholderconcerns at the center of the trading narrative for Nektar Therapeutics , inviting shareholders to contact the firm for more information about the investigation. That invitation does not by itself establish the outcome of any claim. Separately, a jury …
The FDA clearance covers the PM647 trial for alpha-1 antitrypsin deficiency, tying the regulatory action to one named program rather than to the whole of Prime Medicine's business. The clearance moves the application through a regulatory step associated with the planned trial, but it …
Artelo Biosciences submitted a provisional patent application covering ART27.13 for obesity, both as a standalone treatment and in combination with GLP-1 receptor agonists, after unexpected nonclinical findings connected with the program. Because the application is provisional and based on nonclinical findings rather than clinical …
Veracyte (NASDAQ:VCYT) shares surged on heavy volume today, more than 1.6 times average, extending a multi-session rally built on strong underlying fundamentals. Second-quarter results beat expectations with adjusted earnings per share of $0.54, up 25.6% compared with consensus estimates, and revenue of $150.3 million, …
Viking Therapeutics (NASDAQ:VKTX) shares closed sharply lower today, giving back most of Tuesday's 36% surge after the company priced an upsized $500 million financing package. The package includes 7.86 million shares of common stock priced at $35 per share, a discount to Wednesday's close, …
Tandem Diabetes Care (NASDAQ:TNDM) shares closed lower today, extending Wednesday's 7.8% drop, as broader healthcare sentiment stays pressured following the Centers forMedicareand Medicaid Services' move to cancel Affordable Care Act coverage for roughly 760,000 people and claw back an estimated $2.2 billion in subsidies. …
Twist Bioscience (NASDAQ:TWST) shares closed sharply higher today, extending a multi-week rally driven by its September announcement of joining Eli Lilly's (NYSE:LLY) TuneLab platform as a preferred antibody characterization data provider. Investors see the partnership as validating Twist's AI-enabled antibody discovery capabilities, a milestone …
10x Genomics (NASDAQ:TXG) shares closed sharply higher today, touching a fresh 52-week high and extending a multi-day rally built on renewed confidence in the company's growth trajectory following its August earnings beat. The rally has been reinforced by raised full-year 2026 revenue guidance of …
Thermo Fisher Scientific (NYSE:TMO) shares closed at a fresh all-time high today, extending a rally rooted in strong second-quarter earnings. The company reported adjusted earnings per share of $6.03 versus a $5.71 estimate, alongside roughly 10% sales growth, and raised its full-year guidance, reinforcing …
Perrigo (NYSE:PRGO) shares closed sharply higher today, rebounding from Wednesday's 3.3% decline, as investors responded to a fresh wave of bullish analyst sentiment. A research firm upgraded the stock last week, and a separateValuation Analysisflagged the shares as undervalued relative to fair-value estimates following …
Please wait processing your request...